SAT0333 Prevalence of sarcopenia in patients with systemic sclerosis according to the revised criteria of the european working group on sarcopenia in older people

Background

Systemic Sclerosis (SSc) is a chronic inflammatory connective tissue disease that is often associated with gastrointestinal involvement and myopathy. Sarcopenia is defined as age-associated loss of muscle mass, strength and function with profound impact on functionality as well as on mortality (1). “Secondary sarcopenia” has now been described in the context of severe and chronic disease such as malignant disease or...